• Investors
  • |
  • Join Our Team
  • Immune Medicine
    Immune Medicine Platform
    The Adaptive Immune System
    Research Publications
  • Products & Pipeline
    Life Sciences Research
    immunoSEQ
    immunoSEQ T-MAP
    Clinical Diagnostics
    clonoSEQ
    T-Detect
    Drug Discovery
    Cellular Therapy
    Neutralizing Antibodies
    Vaccines
    Pipeline
    Clinical Portfolio & Pipeline
    Partners
    Biopharma Partners
    Technology Partners
  • News & Events
    MEDIA
    Press Releases
    Media Resources
    BLOG
    Powering the Age of Immune Medicine
    The Case for T cells
    Great News for Blood Cancer Patients
    A Testing Renaissance
    See all posts
    events
    Conferences & Events
    Webinars
  • Our Science
    Clinical Studies
    ImmuneRACE
    ImmuneSense Lyme
    medical
    Medical Affairs
    Medical Information
    Data & Congresses
    DATA PROGRAMS
    ImmuneCODE
    ImmuneACCESS
    PUBLICATIONS
    Research Publications
    EDUCATION
    SEQDiscovery
  • About Us
    ABOUT US
    Who We Are
    Our Story
    Innovation Timeline
    Leadership
    INVESTORS
    Investor Relations
    Newsroom
    CONNECT
    Contact
    Careers
  • IMMUNE MEDICINE
    • Immune Medicine Platform
    • The Adaptive Immune System
    • Research Publications
  • PRODUCTS & PIPELINE
    • LIFE SCIENCES RESEARCH
    • immunoSEQ
    • immunoSEQ T-MAP
    • CLINICAL DIAGNOSTICS
    • clonoSEQ
    • T-Detect
    • DRUG DISCOVERY
    • Cellular Therapy
    • Neutralizing Antibodies
    • Vaccines
    • PIPELINE
    • Clinical Portfolio & Pipeline
    • PARTNERS
    • Biopharma Partners
    • Technology Partners
  • NEWS & EVENTS
    • MEDIA
    • Press Releases
    • Media Resources
    • BLOG
    • Powering the Age of Immune Medicine
    • The Case for T Cells
    • Great News for Blood Cancer Patients
    • A Testing Renaissance
    • See all posts ➔
    • EVENTS
    • Conferences & Events
    • Webinars
  • OUR SCIENCE
    • CLINICAL
    • ImmuneRACE
    • ImmuneSense Lyme
    • MEDICAL
    • Medical Affairs
    • Medical Inquiries
    • Data & Congresses
    • DATA PROGRAMS
    • ImmuneCODE
    • ImmuneACCESS
    • PUBLICATIONS
    • Research Publications
  • ABOUT US
    • ABOUT US
    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • INVESTORS
    • Investor Relations
    • Newsroom
    • CONNECT
    • Contact
    • Careers
Menu
  • IMMUNE MEDICINE
    • Immune Medicine Platform
    • The Adaptive Immune System
    • Research Publications
  • PRODUCTS & PIPELINE
    • LIFE SCIENCES RESEARCH
    • immunoSEQ
    • immunoSEQ T-MAP
    • CLINICAL DIAGNOSTICS
    • clonoSEQ
    • T-Detect
    • DRUG DISCOVERY
    • Cellular Therapy
    • Neutralizing Antibodies
    • Vaccines
    • PIPELINE
    • Clinical Portfolio & Pipeline
    • PARTNERS
    • Biopharma Partners
    • Technology Partners
  • NEWS & EVENTS
    • MEDIA
    • Press Releases
    • Media Resources
    • BLOG
    • Powering the Age of Immune Medicine
    • The Case for T Cells
    • Great News for Blood Cancer Patients
    • A Testing Renaissance
    • See all posts ➔
    • EVENTS
    • Conferences & Events
    • Webinars
  • OUR SCIENCE
    • CLINICAL
    • ImmuneRACE
    • ImmuneSense Lyme
    • MEDICAL
    • Medical Affairs
    • Medical Inquiries
    • Data & Congresses
    • DATA PROGRAMS
    • ImmuneCODE
    • ImmuneACCESS
    • PUBLICATIONS
    • Research Publications
  • ABOUT US
    • ABOUT US
    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • INVESTORS
    • Investor Relations
    • Newsroom
    • CONNECT
    • Contact
    • Careers

Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes

Read the latest
from Adaptive

Immune Medicine
  • Immune Medicine Platform
  • The Adaptive Immune
    System
  • Research Publications
Products & Platform
  • immunoSEQ
  • immunoSEQ T-Map
  • clonoSEQ
  • T-Detect
  • Cellular Therapy
  • Neutralizing Antibodies
  • Vaccines
  • Pipeline
  • Technology Partners
  • Biopharma Partnerships
News & Events
  • Press Releases
  • Blog
  • Media Resources
  • Webinars
  • Conferences & Events
Our Science
  • ImmuneRACE
  • ImmunseSense Lyme
  • Research Publications
  • ImmuneCODE
  • ImmuneACCESS
  • Medical Affairs
  • Medical Inquiries
  • Data & Congresses
  • SEQDiscovery
About Us
  • Who We Are
  • Our Story
  • Innovation Timeline
  • Leadership
  • Investor Relations
  • Newsroom
  • Careers
  • Contact Us

Diagnostics (888) 552-8988 | Corporate/Research (855) 466-8667

© Adaptive Biotechnologies. All Rights Reserved. Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct
Facebook-f
Youtube
Twitter
Instagram
Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.
Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

Diagnostics (888) 552-8988

Corporate/Research (855) 466-8667

Facebook-f
Youtube
Twitter
Instagram
Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.

Online Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

STAY IN TOUCH

Receive the latest

Adaptive news and updates

Your email is safe with us. Read our Privacy Policy.

Adaptive is ringing in the new year with a new identity
Read More